anthrax.biotechnology
This comes as shocking news for VaxGen. FDA has postponed the advanced testing of anthrax vaccine being developed by the company. The second mid stage clinical trials of the vaccine were about to begin. The reason for this is that FDA found out the...
Related Stories
Most Recent
Most Popular
Most Commented
All Stories
Most Recent
Most Popular
Most Commented
Home

RSS